Suppr超能文献

前列腺癌放射治疗的全球研究现状与热点:基于2010 - 2022年科学网的文献计量分析

Global research status and hotspots of radiotherapy for prostate cancer: a bibliometric analysis based on Web of Science from 2010-2022.

作者信息

Xie Xiaodu, Zhang Peng, Ran Chongjun, Liu Lumiao, Hu Jian, Lei Pan, Liang Peihe

机构信息

Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, ;China.

Department of Anesthesiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

出版信息

Front Oncol. 2023 Aug 11;13:1135052. doi: 10.3389/fonc.2023.1135052. eCollection 2023.

Abstract

BACKGROUND

Radiotherapy (RT) is one of the important treatments for various cancer types and its application to prostate cancer (PCa) has also gradually gained increasing attention. However, there is a lack of comprehensive and objective studies on the overall status of research on RT for PCa. This article aims to summarize and quantify the dynamic trends of RT in PCa by using bibliometrics.

METHODS

Studies on RT for PCa were screened from the Web of Science Core Collection (WoSCC) database between 1 January 2010 and 21 November 2022 to collate and quantify information characteristics by analyzing parameters including annual publications, countries/regions, institutions and authors with the aid of the bibliometric software CiteSpace and VOSviewer. In addition, research trends and hotspots were explored by analyzing keywords and co-cited references.

RESULTS

A total of 21338 documents were retrieved. The United States of America (USA) ranked first and maintained the leading position among all countries in the number of publications (8489) and total citations (266342). The University of Toronto was the most active institution in total publications (n=587). Paul L Nguyen enjoyed the most publications (n=179), and Michael J Zelefsky enjoyed the most co-citations (n=3376). published the most papers (n=1026), and was the most frequently co-cited journal (n=78550). The largest and closest cluster in the reference cluster analysis was "oligorecurrent prostate cancer". The timeline view of keywords reveals that cluster "biochemical recurrence(BCR)" is ongoing. Moreover, keywords burstness analysis showed that "radiation dosimetry", "dose rate brachytherapy(BT)", "salvage radiotherapy", "stereotactic body radiotherapy(SBRT)", "guideline", and "multicenter" were the terms with great bursts in the past a few years.

CONCLUSION

The application of RT targeting oligometastatic prostate cancer(OMPC) has garnered considerable attention among researchers. SBRT and BT have become hot topics in the field. Additionally, the BCR of PCa has long been a critical issue requiring extensive research and resolution, and salvage radiotherapy has currently emerged as a closely related research focus. Related large-scale multicenter studies have been conducted over the past few years, providing valuable insights. More high-quality research is expected to be employed to guide clinical decision-making.

摘要

背景

放射治疗(RT)是多种癌症类型的重要治疗方法之一,其在前列腺癌(PCa)中的应用也逐渐受到越来越多的关注。然而,目前缺乏关于PCa放射治疗研究总体状况的全面、客观研究。本文旨在运用文献计量学方法总结和量化PCa放射治疗的动态趋势。

方法

从2010年1月1日至2022年11月21日的Web of Science核心合集(WoSCC)数据库中筛选关于PCa放射治疗的研究,借助文献计量软件CiteSpace和VOSviewer,通过分析年度出版物、国家/地区、机构和作者等参数来整理和量化信息特征。此外,通过分析关键词和共被引参考文献来探索研究趋势和热点。

结果

共检索到21338篇文献。美国在出版物数量(8489篇)和总被引次数(266342次)方面均排名第一,并在所有国家中保持领先地位。多伦多大学是出版物总数最多的活跃机构(n = 587)。Paul L Nguyen发表的论文最多(n = 179),Michael J Zelefsky的共被引次数最多(n = 3376)。发表的论文最多(n = 1026),且是被引频率最高的期刊(n = 78550)。参考文献聚类分析中最大且最紧密的聚类是“寡转移前列腺癌”。关键词的时间线视图显示聚类“生化复发(BCR)”仍在持续。此外,关键词突现分析表明,“放射剂量学”“剂量率近距离放疗(BT)”“挽救性放疗”“立体定向体部放疗(SBRT)”“指南”和“多中心”是过去几年中突现性较大的术语。

结论

针对寡转移前列腺癌(OMPC)的放射治疗应用在研究人员中受到了相当大的关注。SBRT和BT已成为该领域的热门话题。此外,PCa的BCR长期以来一直是一个需要广泛研究和解决的确切问题,挽救性放疗目前已成为密切相关的研究重点。过去几年进行了相关大规模多中心研究,提供了有价值的见解。预计将采用更多高质量研究来指导临床决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48d/10450940/dd6103824194/fonc-13-1135052-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验